Log in

NYSEAMERICAN:AMPEAmpio Pharmaceuticals Stock Price, Forecast & News

+0.06 (+5.71 %)
(As of 08/4/2020 04:00 PM ET)
Today's Range
Now: $1.11
50-Day Range N/A
52-Week Range
Now: $1.11
Volume2.67 million shs
Average Volume2.26 million shs
Market Capitalization$182.98 million
P/E RatioN/A
Dividend YieldN/A
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.
Read More
Ampio Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A



Market Cap$182.98 million
Next Earnings Date11/5/2020 (Estimated)
+0.06 (+5.71 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Ampio Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ampio Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Ampio Pharmaceuticals

When is Ampio Pharmaceuticals' next earnings date?

Ampio Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Ampio Pharmaceuticals

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) issued its quarterly earnings results on Wednesday, May, 6th. The specialty pharmaceutical company reported ($0.04) EPS for the quarter, meeting analysts' consensus estimates of ($0.04).
View Ampio Pharmaceuticals' earnings history

What price target have analysts set for AMPE?

1 equities research analysts have issued twelve-month price targets for Ampio Pharmaceuticals' stock. Their forecasts range from $4.00 to $4.00. On average, they expect Ampio Pharmaceuticals' share price to reach $4.00 in the next twelve months. This suggests a possible upside of 260.4% from the stock's current price.
View analysts' price targets for Ampio Pharmaceuticals

Has Ampio Pharmaceuticals been receiving favorable news coverage?

News articles about AMPE stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ampio Pharmaceuticals earned a news impact score of -1.0 on InfoTrie's scale. They also gave news headlines about the specialty pharmaceutical company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the near future.
View the latest news about Ampio Pharmaceuticals

Who are some of Ampio Pharmaceuticals' key competitors?

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Trevena (TRVN), Cerus (CERS), NovaBay Pharmaceuticals (NBY), AVEO Pharmaceuticals (AVEO), Athersys (ATHX), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Protalix Biotherapeutics (PLX), Rigel Pharmaceuticals (RIGL) and Arena Pharmaceuticals (ARNA).

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the following people:
  • Mr. Michael E. Macaluso, Founder, Chairman & CEO (Age 67)
  • Mr. Thomas E. Chilcott III, CFO, Treasurer & Sec. (Age 51)
  • Ms. Holli Cherevka, Chief Operating Officer (Age 36)

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

Who are Ampio Pharmaceuticals' major shareholders?

Ampio Pharmaceuticals' stock is owned by a number of institutional and retail investors. Top institutional investors include Wedbush Securities Inc. (0.06%) and Chicago Partners Investment Group LLC (0.04%).
View institutional ownership trends for Ampio Pharmaceuticals

Which major investors are selling Ampio Pharmaceuticals stock?

AMPE stock was sold by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..
View insider buying and selling activity for Ampio Pharmaceuticals

Which major investors are buying Ampio Pharmaceuticals stock?

AMPE stock was bought by a variety of institutional investors in the last quarter, including Chicago Partners Investment Group LLC.
View insider buying and selling activity for Ampio Pharmaceuticals

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $1.11.

How big of a company is Ampio Pharmaceuticals?

Ampio Pharmaceuticals has a market capitalization of $182.98 million. Ampio Pharmaceuticals employs 22 workers across the globe.

What is Ampio Pharmaceuticals' official website?

The official website for Ampio Pharmaceuticals is ampiopharma.com.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company can be reached via phone at +1-720-4376500.

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.